Author: Ng, Jia H.; Bijol, Vanesa; Sparks, Matthew A.; Sise, Meghan E.; Izzedine, Hassane; Jhaveri, Kenar D.
Title: Pathophysiology of Acute Kidney Injury in Patients with COVID-19 Cord-id: vhd7ahsc Document date: 2020_10_20
ID: vhd7ahsc
Snippet: Acute kidney injury (AKI) is common among hospitalized patients with Coronavirus Infectious Disease 2019 (COVID-19), with the occurrence of AKI ranging from 0.5% to 80%. The variability in the occurrence of AKI has been attributed to the difference in geographic locations, race/ethnicity, and severity of illness. AKI among hospitalized patients is associated with increased length of stay and in-hospital deaths. Even patients with AKI who survive to hospital discharge are at risk of developing ch
Document: Acute kidney injury (AKI) is common among hospitalized patients with Coronavirus Infectious Disease 2019 (COVID-19), with the occurrence of AKI ranging from 0.5% to 80%. The variability in the occurrence of AKI has been attributed to the difference in geographic locations, race/ethnicity, and severity of illness. AKI among hospitalized patients is associated with increased length of stay and in-hospital deaths. Even patients with AKI who survive to hospital discharge are at risk of developing chronic kidney disease (CKD) or end-stage kidney disease (ESKD). An improved knowledge of the pathophysiology of AKI in COVID-19 is crucial to mitigate and manage AKI and to improve the survival of patients who developed AKI during COVID-19. The goal of this article is to provide our current understanding of the etiology and the pathophysiology of AKI in the setting of COVID-19.
Search related documents:
Co phrase search for related documents- academic hospital and acute ards respiratory distress syndrome: 1
- academic hospital and acute kidney injury: 1, 2, 3, 4, 5, 6, 7
- academic hospital and live patient: 1
- academic hospital and liver cirrhosis: 1
- academic hospital and lopinavir ritonavir: 1
- academic hospital and low molecular weight: 1, 2
- academic hospital and low molecular weight proteinuria: 1
- activation immune and acute aki kidney injury: 1, 2, 3, 4, 5, 6, 7, 8
- activation immune and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41
- activation immune and acute kidney injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- activation immune and acute tubular injury: 1
- activation immune and liver cirrhosis: 1, 2, 3, 4, 5
- activation immune and lopinavir ritonavir: 1, 2, 3, 4
- activation immune and low expression: 1, 2, 3, 4, 5, 6, 7, 8, 9
- activation immune and low molecular weight: 1, 2, 3, 4, 5, 6
- activation immune and macrophage activation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47
- activation immune and macrophage activation syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- acute aki kidney injury and liver cirrhosis: 1, 2, 3
- acute aki kidney injury and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8
Co phrase search for related documents, hyperlinks ordered by date